Why a cannabis CEO matters to trucking right now
Kim Rivers, the 48-year-old founder and CEO of Trulieve, has been a central figure in cannabis’ fast-changing federal landscape. After President Donald Trump signed an executive order on December 18, 2025 to push marijuana toward Schedule III, the Justice Department issued a final order in late April reclassifying FDA‑approved and state‑licensed medical marijuana, while stopping short of nationwide recreational legalization. That nuance matters for freight: more medical supply could move within legal channels, but the patchwork remains.
The Treasury Department and IRS followed on April 23, 2026, announcing they will issue guidance on how rescheduling affects taxes—including how and when Section 280E (which historically disallowed ordinary deductions for Schedule I/II “trafficking”) will cease to apply to qualifying medical businesses and how mixed operations should apportion expenses. Expect stronger balance sheets at well‑capitalized operators and more disciplined purchasing, warehousing and private-fleet moves as guidance phases in.
Rivers’ strategy: vertical integration, political savvy, and cash to scale
Rivers built Trulieve around “extreme vertical integration”—owning cultivation, processing, transport, storage and retail—letting the company squeeze costs and control quality across intrastate networks like Florida. Her approach reframed cannabis retail as a premium wellness experience, distinct from counterculture imagery, and has made her one of the industry’s most influential executives in Washington.
The numbers show why carriers should pay attention: Trulieve reported roughly $1.2 billion in 2025 revenue and ended the year with 233 retail locations (234 as of early 2026), alongside more than four million square feet of cultivation and processing capacity—scale that begets steady, security‑sensitive freight.
Rivers also pressed on taxes. Trulieve disclosed receiving about $114 million in IRS refunds tied to amended returns challenging prior 280E assessments, underscoring how rescheduling and forthcoming guidance could further improve operators’ cash flows—and their logistics budgets.
Bottom line for fleet managers and owner‑operators
- Compliance is unchanged for CDL holders: DOT’s drug and alcohol rules still prohibit marijuana use for safety‑sensitive employees. Even as medical cannabis shifts to Schedule III, DOT’s guidance and Part 40 procedures remain in force unless and until DOT says otherwise. Do not assume a policy change—treat it like alcohol: any positive for marijuana is disqualifying.
- Positive tests remain a real business risk: Marijuana has been the leading substance in FMCSA Clearinghouse violations in recent years, costing carriers time, turnover and training dollars. Reinforce your policy, supervisor training and RTD workflows now.
- Expect more intrastate, security‑sensitive moves: State‑licensed medical supply chains will expand as tax headwinds recede and access grows. Most large operators run in‑house transport for tight chain‑of‑custody, but rising throughput creates overflow and backfill opportunities for vetted third‑party carriers with secure facilities, vetted drivers and documented SOPs.
- Mind the patchwork—and routing: The DOJ order does not legalize recreational cannabis nationwide. Licensure, manifests, vehicle security specs and packaging rules differ widely by state. Until federal rules further clarify interstate movement, treat borders as hard stops for cannabis cargo and bake geofencing and contingency routing into TMS.
- Prepare for faster payment cycles from stronger counterparties: Treasury/IRS guidance is expected to remove 280E burdens for qualifying medical activity and clarify expense apportionment. That can translate into healthier AR/AP dynamics and more predictable tendering, but contracting should still address seizure risk, indemnification and insurance endorsements (cargo/theft, high‑value pharmaceuticals).
What to watch next
For now, treat cannabis hauling as a specialized, intrastate‑first niche with heavy documentation and security requirements. Rivers’ playbook—vertical integration, regulatory fluency and financial discipline—suggests larger, steadier volumes for licensed medical markets through 2026. But for drivers, nothing changes on use: zero tolerance under DOT remains the operative rule. As Treasury and IRS finalize tax guidance, and as states fine‑tune licensing and distribution, carriers positioned with compliant SOPs, dedicated secure capacity and strong shipper vetting will be best placed to win freight without regulatory missteps.
The takeaway: with Rivers helping pull cannabis further into the financial mainstream, freight demand around licensed medical products is likely to firm up—yet the safest margin for trucking lies in airtight compliance, intrastate discipline and contracts built for a still‑fragmented regulatory map.
Sources Consulted: El País (English edition); U.S. Department of the Treasury; The Washington Post; U.S. DOT/ODAPC and FMCSA Clearinghouse; Trulieve Investor Relations.
Need to file your Form 2290?
Join thousands of owner-operators and carriers who trust HeavyTax.com for fast and easy HVUT e-filing.
This article was prepared exclusively for truckstopinsider.com. For professional tax advice, consult a qualified professional.
